National Bank of Canada’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-473,500
Closed -$28M 2725
2023
Q4
$28M Buy
+473,500
New +$28M 0.04% 282
2023
Q3
Sell
-89,000
Closed -$3.39M 2663
2023
Q2
$3.39M Sell
89,000
-252,200
-74% -$9.6M 0.01% 733
2023
Q1
$12.7M Sell
341,200
-26,100
-7% -$970K 0.03% 323
2022
Q4
$16.6M Buy
367,300
+115,300
+46% +$5.22M 0.04% 277
2022
Q3
$17.6M Sell
252,000
-247,000
-49% -$17.3M 0.09% 215
2022
Q2
$33.5M Buy
499,000
+498,854
+341,681% +$33.5M 0.15% 121
2022
Q1
$12K Sell
146
-49,000
-100% -$4.03M ﹤0.01% 2098
2021
Q4
$7.21M Buy
+49,146
New +$7.21M 0.02% 395